Amoon Growth Fund Limited Partnership - Net Worth and Insider Trading
Amoon Growth Fund Limited Partnership Net Worth
The estimated net worth of Amoon Growth Fund Limited Partnership is at least $11 Million dollars as of 2024-04-28. Amoon Growth Fund Limited Partnership is the 10% Owner of Seer Inc and owns about 4,923,196 shares of Seer Inc (SEER) stock worth over $9 Million. Amoon Growth Fund Limited Partnership is also the 10% Owner of Ayala Pharmaceuticals Inc and owns about 2,991,473 shares of Ayala Pharmaceuticals Inc (ADXS) stock worth over $2 Million. Details can be seen in Amoon Growth Fund Limited Partnership's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amoon Growth Fund Limited Partnership has not made any transactions after 2021-06-09 and currently still holds the listed stock(s).
Transaction Summary of Amoon Growth Fund Limited Partnership
Amoon Growth Fund Limited Partnership Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amoon Growth Fund Limited Partnership owns 4 companies in total, including Ayala Pharmaceuticals Inc (ADXS) , Viracta Therapeutics Inc (VIRX) , and Seer Inc (SEER) among others .
Insider Ownership Summary of Amoon Growth Fund Limited Partnership
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADXS | Ayala Pharmaceuticals Inc | 2020-05-12 | 10 percent owner |
| VIRX | Viracta Therapeutics Inc | 2021-02-24 | 10 percent owner |
| SEER | Seer Inc | 2021-06-09 | 10 percent owner |
| ADXS | Advaxis Inc | 2023-01-19 | 10 percent owner |
Amoon Growth Fund Limited Partnership Latest Holdings Summary
Amoon Growth Fund Limited Partnership currently owns a total of 2 stocks. Among these stocks, Amoon Growth Fund Limited Partnership owns 4,923,196 shares of Seer Inc (SEER) as of June 9, 2021, with a value of $9 Million and a weighting of 84.99%. Amoon Growth Fund Limited Partnership also owns 2,991,473 shares of Ayala Pharmaceuticals Inc (ADXS) as of May 12, 2020, with a value of $2 Million and a weighting of 15.01%.
Latest Holdings of Amoon Growth Fund Limited Partnership
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SEER | Seer Inc | 2021-06-09 | 4,923,196 | 1.91 | 9,403,304 |
| ADXS | Ayala Pharmaceuticals Inc | 2020-05-12 | 2,991,473 | 0.56 | 1,660,268 |
Holding Weightings of Amoon Growth Fund Limited Partnership
Amoon Growth Fund Limited Partnership Form 4 Trading Tracker
According to the SEC Form 4 filings, Amoon Growth Fund Limited Partnership has made a total of 2 transactions in Seer Inc (SEER) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Seer Inc is the sale of 1,000,000 shares on June 9, 2021, which brought Amoon Growth Fund Limited Partnership around $30 Million.
According to the SEC Form 4 filings, Amoon Growth Fund Limited Partnership has made a total of 1 transactions in Ayala Pharmaceuticals Inc (ADXS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ayala Pharmaceuticals Inc is the acquisition of 800,000 shares on May 12, 2020, which cost Amoon Growth Fund Limited Partnership around $12 Million.
Insider Trading History of Amoon Growth Fund Limited Partnership
- 1
Amoon Growth Fund Limited Partnership Trading Performance
GuruFocus tracks the stock performance after each of Amoon Growth Fund Limited Partnership's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amoon Growth Fund Limited Partnership is -26.22%. GuruFocus also compares Amoon Growth Fund Limited Partnership's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amoon Growth Fund Limited Partnership within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amoon Growth Fund Limited Partnership's insider trading performs compared to the benchmark.
Performance of Amoon Growth Fund Limited Partnership
Average Return
-47.66%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.55 | -26.22 | -40.72 | -47.66 | -66.39 | -69.09 |
| Relative Return to S&P 500(%) | -10.6 | -37.87 | -59.79 | -81.98 | -76.65 | -79.43 |
Amoon Growth Fund Limited Partnership Ownership Network
Ownership Network List of Amoon Growth Fund Limited Partnership
Ownership Network Relation of Amoon Growth Fund Limited Partnership
Amoon Growth Fund Limited Partnership Owned Company Details
What does Ayala Pharmaceuticals Inc do?
Who are the key executives at Ayala Pharmaceuticals Inc?
Amoon Growth Fund Limited Partnership is the 10 percent owner of Ayala Pharmaceuticals Inc. Other key executives at Ayala Pharmaceuticals Inc include other: shareholder of 10% holder Yair Chaim Schindel , director & CEO Roni Mamluk , and Chief Medical Officer Gary B. Gordon .
Ayala Pharmaceuticals Inc (ADXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ayala Pharmaceuticals Inc (ADXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ayala Pharmaceuticals Inc (ADXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ayala Pharmaceuticals Inc (ADXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ayala Pharmaceuticals Inc Insider Transactions
Amoon Growth Fund Limited Partnership Mailing Address
Above is the net worth, insider trading, and ownership report for Amoon Growth Fund Limited Partnership. You might contact Amoon Growth Fund Limited Partnership via mailing address: 34 Yerushalayim Rd., Raanana L3 4350110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
